As per Precedence Research, the global cell lysis and disruption market size is expanding around US$ 7.1 billion by 2030 and growing at a CAGR of 6.7% from 2021 to 2030.
As per Precedence Research, the global cell lysis and disruption market size is expanding around US$ 7.1 billion by 2030 and growing at a CAGR of 6.7% from 2021 to 2030.
Cell lysis refers to the breaking down of the cell. It is caused by viral, osmotic, or enzymatic mechanisms. These mechanisms compromise the cells’ integrity. Cell disruption is the method of breaking the cell membrane and walls to obtain intracellular fluids. It is used in western and southern blotting for lipids, proteins, and other biomolecules analysis to degrade sensitive proteins and DNA.
Get the Sample Copy of This Report@ https://www.precedenceresearch.com/sample/1292
Growth Factors
Factors such as the increasing prevalence of chronic diseases, rising research and development activities, and rapid advancements in biopharmaceutical and pharmaceutical industries significantly contribute to cell lysis and disruption market growth. The widespread use of biotechnology processes in bio-services, agricultural, and pharmaceutical industries positively influence the market growth.
The COVID-19 pandemic significantly impacted market growth. The growing research and development activities for the COVID vaccine are catalysing the cell lysis and disruption demand. The market players focus on providing bioprocessing-related solutions, thus propelling the market growth.
Various organizations like government and private companies heavily invest in research and development activities for biotechnological processes and academics. Moreover, an increasing prevalence of chronic disorders and surging demand for novel therapeutics are bolstering market growth.
The biopharmaceutical sector expansion offers numerous opportunities for market expansion. Thus, adopting biotech processes in the pharma, agricultural, and bio-services industries is a positive thrust to market growth. Cell lysis is vital in the bioprocess.
Regional Snapshots
North America accounted for the largest revenue share. The US and Canadian governments support molecular biology, precision medicine, and cancer research, thus driving the market growth. The public and private companies are investing heavily in target therapeutics and novel drug discovery for complicated and rare diseases, thus boosting the market’s growth.
However, Asia Pacific is expected to witness the fastest CAGR over the forecast period. This growth is due to the presence of leading market players. In Asian countries, rapid technological innovations and a regulatory environment that supports innovation fuel market growth. Moreover, the rising popularity of personalized cancer medicine is expected to boost market growth.
Report Highlights
- By technique, the reagent-based method accounted for the largest revenue share. This method is mild and best for laboratory samples. It doesn’t destroy the biological activity of the final products. This method is a good choice for laboratory usage, thus driving the segment’s growth. Before, the physical disruption method was used by market players for the extraction of intracellular contents. However, the adoption of this method is reduced due to the expensive equipment.
- By product, reagents, and consumables segment captured the largest revenue share. Enzymes are expected to grow at a promising CAGR during the forecast period. The application for the selective product release and controlled lysis is the growth-inducing factor. Different enzymes are available for bacterial, yeast, plant, and mammalian samples.
- By cell type, the mammalian cells segment captured significant revenue and is expected to remain dominant throughout the forecast period. These cells are widely used during bio-manufacturing of vaccines, therapeutic proteins, and other recombinant products. Furthermore, the increasing demand for 3D mammalian culture systems stems cells is boosting the segment’s growth. Also, cancer research activities are driving market expansion.
- By application, the protein isolation segment achieved the highest revenue share. Protein isolation is used in proteomics, western blotting, and immunoprecipitation. Surging demand for lysis techniques to extract the proteins fuels the segment’s growth. The launch of advanced bioprocessing reagents catalyzes market growth. In addition, the launch of equipment that can complement the established disruption procedures boosts market growth.
- By end-use, the pharmaceutical and biotechnology companies segment captured the largest market share. This is due to many biotechnology enterprises exploring molecular biology and bioprocess strategies. Significant growth in the biopharmaceutical industry is driving the segment’s growth. Factors such as the safety and efficacy of biopharmaceutical products and biopharma products’ ability to tackle clinical conditions are boosting market growth. Pharmaceutical companies are focusing on manufacturing biopharmaceutical products, propelling market growth. Cell disruption techniques are widely used in biospecimen banking organizations due to diverse tumorigenicity testing and research protocols. A clinical study for drug development is expected to offer numerous opportunities for the segment’s growth.
Ask Here for Customization@ https://www.precedenceresearch.com/customization/1292
Digital Health Market Report Scope
| Report Coverage | Details |
| Market Size In 2022 | US$ 4.19 Billion |
| Market Size By 2030 | US$ 7.1 Billion |
| Growth Rate From 2022 to 2030 | CAGR of 6.7% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
| Regions Covered |
|
Market Dynamics for Cell Lysis and Disruption Market:
Market Driver: Increasing adoption of biotechnology methods in agricultural, bio-services, and pharma industries
Increasing demand for biotech procedures in agricultural, bio-services, and pharma industries contributes significantly to the global cell lysis and disruption market. The rapid adoption of gene expression protocols offers lucrative market growth opportunities. In line with this, the rising demand for tumor tissue dissociation equipment is expected to drive market growth in the future years. Furthermore, many participants in the mhealth market catalyse the market growth. Moreover, the emergence of new market players boosts the cell lysis and disruption market.
Market Restraint: High costs of equipment
Factors such as the high equipment cost and the shortage of skilled professionals restrict profit generation to a certain extent. High maintenance and costly devices are impeding market growth. Difficulties applying the mechanical method at the microscale stage and regulatory obligations hamper the market growth. This problem can be handled as the governments are releasing funds to support development in the biotechnology sector.
Market Opportunity: Rapid advancements in new products
There has been a rapid advancement of new products due to the surging demand for effective tumor tissue dissociation equipment. This offers numerous opportunities for market growth. The widespread COVID-19 pandemic has positively affected the market of cell lysis and disruption systems. There has been a rising requirement for critical medical solutions and diagnostic kits. Increasing research and development activities to develop COVID-19 vaccines catalyzes market growth. Furthermore, the rapid development of medical facilities and therapeutics boosts market growth.
Market Challenge: Shortage of skilled professionals
Skilled persons and technically sound knowledgeable persons are needed for Cell lysis and disruption. There has been a shortage of such people, especially in developing countries. Thus, challenging the market growth.
Related Reports
- Single-use Bioreactors Market 2022-2030: https://www.precedenceresearch.com/single-use-bioreactors-market
- Gene Synthesis Market 2022-2030: https://www.precedenceresearch.com/gene-synthesis-market
- Stem Cell Therapy Market 2022-2030: https://www.precedenceresearch.com/stem-cell-therapy-market
Key Developments in the Marketplace:
- In Jan 2021, Thermo Fisher Scientific, Inc. announced the acquisition of Henogen S.A. This led to the growth of the company’s capabilities for gene and cell therapies and vaccines and improved cell lysis and disruption.
Market Segmentation
Segments Covered in the Report
By Product
- Instruments
- Reagents
By Cell Type
- Bacteria Cells
- Mammalian Cells
- Plant Cells
- Yeast/Fungi/Algae
By Application
- Cell Organelle Isolation
- Protein Isolation
- Downstream Processing
- Nucleic Acid Isolation
By End Use
- Hospitals and Diagnostic Laboratories
- Cell Banks
- Academic and Research Institutions
- Pharma & Biotechnology Companies
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Click Here to View Full Report Table of Contents
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1292
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333